Literature DB >> 28198028

Proinflammatory chemokines are major mediators of exuberant immune response associated with Influenza A (H1N1) pdm09 virus infection.

Maria Thomas1, Reeta Subramaniam Mani1, Mariamma Philip2, Ranjeeta Adhikary3, Sangeeta Joshi3, Srigiri S Revadi4, Shashidhar Buggi4, Anita Desai1, Ravi Vasanthapuram1.   

Abstract

In India, the case fatality ratio of the pandemic A (H1N1) pdm09 influenza was relatively higher when compared to seasonal Influenza A infection. Hypercytokinemia or "cytokine storm" has been previously implicated in the pathogenesis of other influenza viruses. The present study was undertaken to compare the cytokine profiles of A (H1N1) pdm09 influenza and seasonal H3 infection in Indian population and to correlate the findings with disease severity. Plasma levels of 18 cytokines/chemokines were measured by flow-cytometry using a bead based assay in patients infected with A (H1N1) pdm09 virus (n = 96) and Influenza A seasonal H3 virus (n = 30) categorised into mild, moderate, and severe groups along with healthy controls (n = 36). There was an overall trend indicating an exuberant cytokine/chemokine response in A (H1N1) pdm09 as compared to seasonal H3 influenza, which was more evident in severe cases, suggesting a role for these cytokines/chemokines in the pathogenesis of A(H1N1) pdm09. Increased levels of CXCL-8/IL-8, IL-10, IL-6, and IL-17A were seen in both A(H1N1) pdm09 influenza and seasonal H3 cases when compared to healthy controls. However, dysregulated production of proinflammatory chemokines was seen more pronounced in A (H1N1) pdm09 influenza cases as compared to seasonal H3 cases. This study has brought forth the potential role of chemokines as prognostic indicators of disease severity and outcome. Further research on modulating the host immune response to limit severity of the disease could help in the treatment and management of influenza.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cytokines/chemokines; immunopathology; influenza virus

Mesh:

Substances:

Year:  2017        PMID: 28198028     DOI: 10.1002/jmv.24781

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Testosterone treatment of aged male mice improves some but not all aspects of age-associated increases in influenza severity.

Authors:  Landon G Vom Steeg; Sarah E Attreed; Barry Zirkin; Sabra L Klein
Journal:  Cell Immunol       Date:  2019-09-14       Impact factor: 4.868

2.  Deep sequencing of the mouse lung transcriptome reveals distinct long non-coding RNAs expression associated with the high virulence of H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zenglei Hu; Xiaoquan Wang; Min Gu; Zhao Gao; Yanyan Liang; Chunxi Ma; Xiaowen Liu; Shunlin Hu; Sujuan Chen; Daxing Peng; Xinan Jiao; Xiufan Liu
Journal:  Virulence       Date:  2018       Impact factor: 5.882

3.  COVID-19 versus Seasonal Influenza: Comparison of Profiles of Older Adults Hospitalized in a Short-Term Geriatric Ward in France.

Authors:  Lidvine Godaert; Agnès Cebille; Emeline Proye; Moustapha Dramé
Journal:  Am J Trop Med Hyg       Date:  2021-12-02       Impact factor: 3.707

4.  Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus.

Authors:  Tianhang Chen; Haixia Du; Huifen Zhou; Jiehong Yang; Jiaqi Zhu; Xin Tong; Yuting Yang; Jiayang Wan; Yichen Fan; Yiyu Lu; Yu He; Haitong Wan
Journal:  Biomed Res Int       Date:  2022-02-15       Impact factor: 3.411

5.  Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.

Authors:  Lynette Miroslava Pacheco-Hernández; Jazmín Ariadna Ramírez-Noyola; Itzel Alejandra Gómez-García; Sergio Ignacio-Cortés; Joaquín Zúñiga; José Alberto Choreño-Parra
Journal:  J Interferon Cytokine Res       Date:  2022-06-07       Impact factor: 3.657

6.  Pre-Treatment with Zirconia Nanoparticles Reduces Inflammation Induced by the Pathogenic H5N1 Influenza Virus.

Authors:  Caiyun Huo; Jin Xiao; Kai Xiao; Shumei Zou; Ming Wang; Peng Qi; Tianlong Liu; Yanxin Hu
Journal:  Int J Nanomedicine       Date:  2020-01-30

Review 7.  Controlling Cytokine Storm Is Vital in COVID-19.

Authors:  Lu Tang; Zhinan Yin; Yu Hu; Heng Mei
Journal:  Front Immunol       Date:  2020-11-30       Impact factor: 8.786

8.  A host-based whole genome sequencing study reveals novel risk loci associated with severity of influenza A(H1N1)pdm09 infection.

Authors:  Mo Li; Yongkun Chen; Tao Chen; Shixiong Hu; Luan Chen; Lu Shen; Fangcai Li; Jing Yang; Yan Sun; Dayan Wang; Lin He; Shengying Qin; Yuelong Shu
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

9.  TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients.

Authors:  Kalichamy Alagarasu; Himanshu Kaushal; Pooja Shinde; Mahadeo Kakade; Urmila Chaudhary; Vikram Padbidri; Shashikala A Sangle; Sonali Salvi; Ashish R Bavdekar; Pradeep D'costa; Manohar Lal Choudhary
Journal:  Genes (Basel)       Date:  2021-11-28       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.